skip to primary navigationskip to content
 

CEGX: The spinout that’s measuring the epigenome to improve human health

Cambridge Enterprise will be holding a series of departmental Roadshow events showcasing some of the most prominent research that has spun out of the university.
When Sep 12, 2017
from 06:00 PM to 08:00 PM
Where Pfizer Lecture Theatre, Department of Chemistry, Lensfield Road
Add event to calendar vCal
iCal

These events will provide a networking opportunity to meet like-minded people with an interest in entrepreneurship and is open to academics, postdocs and PhDs alike from across all departments at the University.

On 12 September, hear Dr Jason Mellad, Chief Executive Officer (CEO) at Cambridge Epigenetix, give a talk about the company’s route to commercialisation and how the relationship with Cambridge Enterprise was able to support this journey.

Cambridge Epigenetix, a pioneer in the development of epigenetic sequencing, was founded in 2012 by Prof Shankar Balasubramanian of the Department of Chemistry.

The company is focused on developing best-in-class tools to make studying DNA methylation and DNA hydroxymethylation as easy as studying DNA sequencing.

Further information and details on how to register can be found here.

OPdA Tweets

RSS Feed Latest news

PPD Committee seeking new postdoc representative

May 20, 2019

The PPD Committee is seeking a new postdoc representative, to start from September 2019.

Join the Open Research Steering Committee

Mar 18, 2019

The Open Research Steering Committee are seeking two postdocs (one from STEMM and one from AHSS). Apply by 2 April 2019.

The Borysiewicz Fellows - Meet Team GC Connect

Feb 21, 2019

Meet Team GC Connect - they are on a mission to maximise the global impact of Cambridge research by creating opportunities for researchers to apply their expertise in the context of international development.

View all news